Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
Independent Payment Advisory Board: Congressional Hearings To Repeal Board
One of the largest—and also most controversial—pieces of the Affordable Care Act (ACA or health care reform) is the Independent…
Medtronic Infuse on the Hot Seat a Case of Research Malfeasance or Legal…
Late last month, I recieved several "breaking news" alerts the U.S. Senate Finance Committee had begun an investigation regarding…
Canceled Group Purchasing Organization Contracts Causes Senate Finance…
Recently, Senate Finance Committee Chairman Max Baucus (D-Mont.) initiated an inquiry into recent actions by medical device…
Government Incentives and Life Science Research
In the midst of budget debates and continued concerns over the Affordable Care Act (ACA or health care reform), a number of House…
Senate Special Committee on Aging: FDA and the Reform of the Medical Device…
Continuing the ongoing scrutiny surrounding the regulatory environment for medical devices in America, the Senate Aging Committee …
American Research and Competitiveness Act of 2010
Medical device and pharmaceutical companies face significant regulatory and legal obstacles in developing new and life-saving…
FDA Budget: Trying to Do Everything on Less Money
Recently, the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration…
America Invents Act
Recently, the Senate Judiciary Committee unanimously approved the “America Invents Act” (S. 23), a bill that would overhaul the…
This Week Congress and President – a Potential Collision Course for…
President Obama recently submitted his $3.7 trillion 2012 budget proposal, marking the start of the annual budget process. Then,…
Intellectual Property Jurisdiction Clarification Act of 2011
This week, the senate judiciary committee passed a bi-partisan patent reform legislation that if enacted, would encourage…